Design and synthesis of unprecedented 9-and 10-membered cyclonucleosides with PRMT5 inhibitory activity

Shuhei Kawamura; Rachel L. Palte; Hai-Young Kim; Josep Sauri; Christopher Sondey; My S. Mansueto; Michael D. Altman; Michelle R. Machacek

doi:10.1016/j.bmc.2022.116820

Design and synthesis of unprecedented 9-and 10-membered cyclonucleosides with PRMT5 inhibitory activity

Shuhei Kawamura, Rachel L. Palte, Hai-Young Kim, Josep Sauri, Christopher Sondey, My S. Mansueto, Michael D. Altman, Michelle R. Machacek

Producció científica: Article en revista indexada › Article › Avaluat per experts

6 Cites (Scopus)

Resum

Synthesis of medium-sized rings is known to be challenging due to high transannular strain especially for 9- and 10-membered rings. Herein we report design and synthesis of unprecedented 9- and 10-membered purine 8,5 ' cyclonucleosides as the first cyclonucleoside PRMT5 inhibitors. The cocrystal structure of PRMT5:MEP50 in complex with the synthesized 9-membered cyclonucleoside 1 revealed its binding mode in the SAM binding pocket of PRMT5.

Idioma original	Anglès
Número d’article	116820
Nombre de pàgines	6
Revista	Bioorganic and Medicinal Chemistry
Volum	66
Data online anticipada	de maig 2022
DOIs	https://doi.org/10.1016/j.bmc.2022.116820
Estat de la publicació	Publicada - 15 de jul. 2022
Publicat externament	Sí

Accés al document

10.1016/j.bmc.2022.116820

Altres arxius i enllaços

Enllaç a la publicació de WoS

Com citar-ho

@article{8a3be1641a3a4d03a0b50fd5d77a14a6,

title = "Design and synthesis of unprecedented 9-and 10-membered cyclonucleosides with PRMT5 inhibitory activity",

abstract = "Synthesis of medium-sized rings is known to be challenging due to high transannular strain especially for 9- and 10-membered rings. Herein we report design and synthesis of unprecedented 9- and 10-membered purine 8,5 ' cyclonucleosides as the first cyclonucleoside PRMT5 inhibitors. The cocrystal structure of PRMT5:MEP50 in complex with the synthesized 9-membered cyclonucleoside 1 revealed its binding mode in the SAM binding pocket of PRMT5.",

keywords = "Cyclonucleoside, Medicinal chemistry, Molecular modeling, Nucleoside, Prmt5, PRMT5 inhibitor, X-ray crystallography",

author = "Shuhei Kawamura and Palte, {Rachel L.} and Hai-Young Kim and Josep Sauri and Christopher Sondey and Mansueto, {My S.} and Altman, {Michael D.} and Machacek, {Michelle R.}",

year = "2022",

month = jul,

day = "15",

doi = "10.1016/j.bmc.2022.116820",

language = "English",

volume = "66",

journal = "Bioorganic and Medicinal Chemistry",

issn = "0968-0896",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - Design and synthesis of unprecedented 9-and 10-membered cyclonucleosides with PRMT5 inhibitory activity

AU - Kawamura, Shuhei

AU - Palte, Rachel L.

AU - Kim, Hai-Young

AU - Sauri, Josep

AU - Sondey, Christopher

AU - Mansueto, My S.

AU - Altman, Michael D.

AU - Machacek, Michelle R.

PY - 2022/7/15

Y1 - 2022/7/15

N2 - Synthesis of medium-sized rings is known to be challenging due to high transannular strain especially for 9- and 10-membered rings. Herein we report design and synthesis of unprecedented 9- and 10-membered purine 8,5 ' cyclonucleosides as the first cyclonucleoside PRMT5 inhibitors. The cocrystal structure of PRMT5:MEP50 in complex with the synthesized 9-membered cyclonucleoside 1 revealed its binding mode in the SAM binding pocket of PRMT5.

AB - Synthesis of medium-sized rings is known to be challenging due to high transannular strain especially for 9- and 10-membered rings. Herein we report design and synthesis of unprecedented 9- and 10-membered purine 8,5 ' cyclonucleosides as the first cyclonucleoside PRMT5 inhibitors. The cocrystal structure of PRMT5:MEP50 in complex with the synthesized 9-membered cyclonucleoside 1 revealed its binding mode in the SAM binding pocket of PRMT5.

KW - Cyclonucleoside

KW - Medicinal chemistry

KW - Molecular modeling

KW - Nucleoside

KW - Prmt5

KW - PRMT5 inhibitor

KW - X-ray crystallography

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_univeritat_ramon_llull&SrcAuth=WosAPI&KeyUT=WOS:000802657100004&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1016/j.bmc.2022.116820

DO - 10.1016/j.bmc.2022.116820

M3 - Article

C2 - 35594650

SN - 0968-0896

VL - 66

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

M1 - 116820

ER -

Design and synthesis of unprecedented 9-and 10-membered cyclonucleosides with PRMT5 inhibitory activity

Resum

Accés al document

Altres arxius i enllaços

Fingerprint

Com citar-ho